Locally Optimised Contouring With AI Technology for Radiotherapy

Recruiting N/A Interventional Study
Contouring Segmentation Radiation Therapy Artificial Intelligence Deep Learning
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
444 (estimated)
Sponsor
Royal North Shore Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiatio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years and older who are planned for primary breast malignancy * ECOG performance 0-2 * Ability to understand and willingness to sign a written informed consent document * The target volume must be able to be objectively reviewed by current published national or internationa…
Contacts

Joseph Chan, BSc MBBS PhD FRANZCR

94631300

joseph.chan@health.nsw.gov.au

CONTACT

Heidi Tsang

94631300

heidi.tsang@health.nsw.gov.au

CONTACT